Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice.
about
The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical OverviewT-cell receptor V(alpha) usage by effector CD4+Vbeta11+ T cells mediating graft-versus-host disease directed to minor histocompatibility antigens.Graft-vs.-malignancy with allogeneic blood stem cell transplantation: a potential primary treatment modality.Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy.Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4+ T cell-mediated graft-versus-host disease model.Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation.Influence of tumor vaccines on graft versus tumor activity and graft versus host disease in allogeneic bone marrow transplantation.Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease.Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccinationAcute lymphoid leukemia cells with greater stem cell antigen-1 (Ly6a/Sca-1) expression exhibit higher levels of metalloproteinase activity and are more aggressive in vivo.Recruitment of Donor T Cells to the Eyes During Ocular GVHD in Recipients of MHC-Matched Allogeneic Hematopoietic Stem Cell Transplants.Novel expression of vascular cell adhesion molecule-1 (CD106) by squamous epithelium in experimental acute graft-versus-host diseaseCharacterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cellsGraft-versus-host disease-related cytokine-driven apoptosis depends on p73 in cytokeratin 15-positive target cellsDendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cellsDistinct fates of self-specific T cells developing in irradiation bone marrow chimeras: clonal deletion, clonal anergy, or in vitro responsiveness to self-Mls-1a controlled by hemopoietic cells in the thymusLong-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.Immune reconstitution and graft-versus-host reactions in rat models of allogeneic hematopoietic cell transplantationUnraveling graft-versus-host disease and graft-versus-leukemia responses using TCR Vβ spectratype analysis in a murine bone marrow transplantation model.Murine models of chronic graft-versus-host disease: insights and unresolved issues.Mouse models of bone marrow transplantationBone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect.Biology of chronic graft-versus-host disease: implications for a future therapeutic approach.Treatment of graft-versus-host disease with naturally occurring T regulatory cells.A synthetic random basic copolymer with promiscuous binding to class II major histocompatibility complex molecules inhibits T-cell proliferative responses to major and minor histocompatibility antigens in vitro and confers the capacity to prevent muMouse models of graft-versus-host disease: advances and limitationsPreterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease.Memory CD4+ T cells do not induce graft-versus-host disease.Cellular tumor vaccines administered after T cell-depleted allogeneic bone marrow transplantation induce effective anti-tumor immune responses.A case of chronic GVHD following bone marrow transplantation from a phenotypically HLA-matched unrelated donor.Genetics of graft-versus-host disease, I. A locus on chromosome 1 influences development of acute graft-versus-host disease in a major histocompatibility complex mismatched murine model.Immunomodulatory peptides with high binding affinity for class II MHC molecules for the prevention of graft-versus-host disease.Recent advances in graft-versus-host disease (GVHD) prevention.Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy.Basophils inhibit proliferation of CD4⁺ T cells in autologous and allogeneic mixed lymphocyte reactions and limit disease activity in a murine model of graft versus host disease.Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndrome.Crossing barriers in transplantation.Analysis of graft-versus-host disease (GVHD) and graft rejection using MHC class I-deficient mice.Analysis of memory and effector CD8+ T cell subsets in chronic graft-versus-host disease.A preclinical acute GVHD mouse model based on chemotherapy conditioning and MHC-matched transplantation.
P2860
Q28066083-6ACE701C-4B1B-4178-97F9-31B27BDA0AA1Q33275132-217B48F4-DA3D-4165-BF22-5AD93F4083F0Q33788194-06302D9D-9F82-49A2-AA11-7678294F3288Q34089112-C8F30C21-0341-41B0-A63C-09859AFED70EQ34265880-FEDDD413-00EA-4AA4-9511-2EC41755FDC6Q34557219-B4BE33DE-8602-4E93-B60D-882A8C03ADF3Q34632481-5B5F34AC-F739-44F9-98A7-11E454AD1F17Q34788330-FCF641C3-278D-4574-B490-CE6B6D6A4CA2Q34927696-152DCB99-F859-412E-9141-CDE1078A311AQ35106493-CF483834-F838-4AEB-BC98-4355B483B34CQ35522357-0AF280E2-42FD-4E85-911C-042C3A132CAAQ35789037-8A8B8A27-7CAF-40BC-AF5C-FA91A2C14D1CQ35830507-21AF4789-1BA5-4E7F-B16C-4EFEBB03C9B4Q35962358-3C36809C-BA55-4B62-B8EC-1C62647230D0Q36350884-6AA7C862-9E27-4620-96E5-C44C2642348FQ36353793-28B5C026-F6F7-4C26-84DD-B8831EB24BDEQ36355820-5D51C72C-8B83-4472-BCA5-D5F929B00D14Q36434639-68EF776F-703A-41AE-8C97-25E39E2DA5D2Q36487595-7424C079-D899-4164-BC97-38C77444C603Q36645730-547D35C6-6E1E-4BAA-A94A-C716EC2BDD79Q37045969-6A93246B-D218-4AAB-9162-0D3A0CE92EFDQ37201903-17CDBCC2-BF70-4158-855A-53A128CA753DQ37294468-B6E2038A-E951-4290-AE1B-F5E8F15EC965Q37321716-ADF7A9A4-6279-4CD1-BE11-1FC74C313EA2Q37614042-2E69C869-F2DD-4ABA-ACE5-50E88CFD6825Q37874011-0BE90B44-A11A-491E-9EF5-19164682CBBEQ39737912-04B66452-5C7A-427E-B337-8E1AFA50FDF6Q39778135-65B430D0-3E7E-4CF5-BA08-892764E163E5Q40397719-EC770902-4C77-4CDA-93DE-BCEFDFE1B600Q40702456-116F0E53-064C-452A-91F6-A4050ACC81C9Q40814489-A95D9E00-DA8B-4271-829F-40D51CA48230Q41342013-3667326E-8EED-4958-9CE2-4E1E0DE1B875Q41561701-E0BF0C6E-CE9E-44DE-A840-89CB4A0A297BQ41561713-6544C020-05EB-4378-ACB1-432C618DEABBQ41643992-72A6629E-2264-436E-A8C5-CF1328C2BF0CQ42025658-B18319BD-E534-4052-97F8-A60D3C15E5F6Q42829293-C0D339E3-3B4E-4EC5-9A72-AC974376C676Q47901946-4A54709D-3F48-49FE-AB0A-EA801B9A5A69Q51753173-3F70BE1B-E546-463E-A5D4-E1A7FC156B6FQ52860217-E1BB4060-C4C5-4DBA-AA37-3FA04DB9AEB3
P2860
Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Variable capacity of L3T4+ T c ...... ompatibility barriers in mice.
@en
Variable capacity of L3T4+ T c ...... ompatibility barriers in mice.
@nl
type
label
Variable capacity of L3T4+ T c ...... ompatibility barriers in mice.
@en
Variable capacity of L3T4+ T c ...... ompatibility barriers in mice.
@nl
prefLabel
Variable capacity of L3T4+ T c ...... ompatibility barriers in mice.
@en
Variable capacity of L3T4+ T c ...... ompatibility barriers in mice.
@nl
P2860
P356
P1476
Variable capacity of L3T4+ T c ...... ompatibility barriers in mice.
@en
P2093
P2860
P304
P356
10.1084/JEM.165.6.1552
P407
P577
1987-06-01T00:00:00Z